Gene · 2273
Papers1,852
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,852
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combined sequence and copy number analysis improves diagnosis of limb girdle and other myopathies. | Ann Clin Transl Neurol | 2023 | 37688281 | PubTator, text mining | PubMed |
| Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives. | J Clin Med | 2023 | 37685777 | PubTator, text mining | PubMed |
| Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance. | Nat Commun | 2023 | 37644036 | PubTator, text mining | PubMed |
| Global comparative transcriptomes uncover novel and population-specific gene expression in esophageal squamous cell carcinoma. | Infect Agent Cancer | 2023 | 37641095 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals that immune cells induce human nucleus pulposus ossification and degeneration. | Front Immunol | 2023 | 37638033 | PubTator, text mining | PubMed |
| Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their Modifiers. | Medicina (Kaunas) | 2023 | 37629714 | PubTator, text mining | PubMed |
| CCDC43 as a potential therapeutic target of Tian Yang Wan for the treatment of hepatocellular carcinoma by activating the hippo pathway. | Front Oncol | 2023 | 37614502 | PubTator, text mining | PubMed |
| An extensive β1-adrenergic receptor gene signaling network regulates molecular remodeling in dilated cardiomyopathies. | JCI Insight | 2023 | 37606047 | PubTator, text mining | PubMed |
| Molecular insights using spatial transcriptomics of the distal lung in congenital diaphragmatic hernia. | Am J Physiol Lung Cell Mol Physiol | 2023 | 37605849 | PubTator, text mining | PubMed |
| Advanced searching for hypertrophic cardiomyopathy heritability in real practice tomorrow. | Front Cardiovasc Med | 2023 | 37583586 | PubTator, text mining | PubMed |
| Biallelic truncating variants in children with titinopathy represent a recognizable condition with distinctive muscular and cardiac characteristics: a report on five patients. | Front Cardiovasc Med | 2023 | 37576110 | PubTator, text mining | PubMed |
| Distinct Clades of Protein Phosphatase 2A Regulatory B'/B56 Subunits Engage in Different Physiological Processes. | Int J Mol Sci | 2023 | 37569631 | PubTator, text mining | PubMed |
| Integrated multiomics analysis of chromosome 19 miRNA cluster in bladder cancer. | Funct Integr Genomics | 2023 | 37542643 | PubTator, text mining | PubMed |
| Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies. | Curr Opin Rheumatol | 2023 | 37503636 | PubTator, text mining | PubMed |
| The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy. | Front Oncol | 2023 | 37483519 | PubTator, text mining | PubMed |
| A comprehensive study of skeletal muscle imaging in FHL1-related reducing body myopathy. | Ann Clin Transl Neurol | 2023 | 37483011 | PubTator, text mining | PubMed |
| A distinct variant of the SzM protein of Streptococcus equi subsp. zooepidemicus recruits C1q independent of IgG binding and inhibits activation of the classical complement pathway. | Virulence | 2023 | 37450582 | PubTator, text mining | PubMed |
| Comparative Analysis of Water Extracts from Roselle (Hibiscus sabdariffa L.) Plants and Callus Cells: Constituents, Effects on Human Skin Cells, and Transcriptome Profiles. | Int J Mol Sci | 2023 | 37446030 | PubTator, text mining | PubMed |
| Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis? | Int J Mol Sci | 2023 | 37445645 | PubTator, text mining | PubMed |
| Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment. | Cancers (Basel) | 2023 | 37444584 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2273/papers?page=8